These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1913615)

  • 41. Enhanced liver tumor promotion activity in rats subjected to combined administration of phenobarbital and orphenadrine.
    Morita R; Yafune A; Shiraki A; Itahashi M; Akane H; Nakane F; Suzuki K; Shibutani M; Mitsumori K
    J Toxicol Sci; 2013; 38(3):415-24. PubMed ID: 23665940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of rapid initiating, promoting or sequential syncarcinogenic effects of di(2-ethylhexyl)phthalate in rat liver carcinogenesis.
    Williams GM; Maruyama H; Tanaka T
    Carcinogenesis; 1987 Jul; 8(7):875-80. PubMed ID: 3594721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibition of chemically induced mammary carcinogenesis in rats by long-term exposure to butylated hydroxytoluene (BHT): interrelations among BHT concentration, carcinogen dose, and diet.
    Cohen LA; Choi K; Numoto S; Reddy M; Berke B; Weisburger JH
    J Natl Cancer Inst; 1986 Apr; 76(4):721-30. PubMed ID: 3083149
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppressive effect of irsogladine maleate on diethylnitrosamine-initiated and phenobarbital-promoted hepatocarcinogenesis in male F344 rats.
    Sugie S; Okamoto K; Ueda F; Watanabe T; Tanaka T; Mori H
    Jpn J Cancer Res; 1998 Apr; 89(4):371-6. PubMed ID: 9617341
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
    Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
    Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative stereologic study of the effects of varying the time between initiation and promotion on four histochemical markers in rat liver during hepatocarcinogenesis.
    Xu YH; Maronpot R; Pitot HC
    Carcinogenesis; 1990 Feb; 11(2):267-72. PubMed ID: 1967985
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protective effects of butylated hydroxytoluene on the initiation of N-nitrosodiethylamine-induced hepatocellular carcinoma in albino rats.
    Fahim SA; Ibrahim S; Tadros SA; Badary OA
    Hum Exp Toxicol; 2023; 42():9603271231165664. PubMed ID: 36943693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparative analysis of the effect of phenobarbital, dichlorodiphenyltrichloroethane, butylated hydroxytoluene and nafenopin on rat hepatocarcinogenesis.
    Préat V; de Gerlache J; Lans M; Taper H; Roberfroid M
    Carcinogenesis; 1986 Jun; 7(6):1025-8. PubMed ID: 2871946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Soybean isoflavone extract suppresses early but not later promotion of hepatocarcinogenesis by phenobarbital in female rat liver.
    Lee KW; Wang HJ; Murphy PA; Hendrich S
    Nutr Cancer; 1995; 24(3):267-78. PubMed ID: 8610046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anticarcinogenic effects of cadmium in B6C3F1 mouse liver and lung.
    Waalkes MP; Diwan BA; Weghorst CM; Bare RM; Ward JM; Rice JM
    Toxicol Appl Pharmacol; 1991 Sep; 110(2):327-35. PubMed ID: 1891777
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative merits of immunohistochemical demonstrations of placental, A, B and C forms of glutathione S-transferase and histochemical demonstration of gamma-glutamyl transferase as markers of altered foci during liver carcinogenesis in rats.
    Tatematsu M; Mera Y; Ito N; Satoh K; Sato K
    Carcinogenesis; 1985 Nov; 6(11):1621-6. PubMed ID: 2865013
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of altered hepatocyte foci by separate and combined treatments with radiation and diethylnitrosamine in neonatal rats.
    Kim SH; Lee YS; Lee MS; Kim TH; Jang JJ
    J Korean Med Sci; 1994 Aug; 9(4):313-8. PubMed ID: 7848579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 1alpha, 25-dihydroxyvitamin D3 prevents DNA damage and restores antioxidant enzymes in rat hepatocarcinogenesis induced by diethylnitrosamine and promoted by phenobarbital.
    Banakar MC; Paramasivan SK; Chattopadhyay MB; Datta S; Chakraborty P; Chatterjee M; Kannan K; Thygarajan E
    World J Gastroenterol; 2004 May; 10(9):1268-75. PubMed ID: 15112340
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Loss of tumor-promoting activity of unleaded gasoline in N-nitrosodiethylamine-initiated ovariectomized B6C3F1 mouse liver.
    Moser GJ; Wolf DC; Wong BA; Goldsworthy TL
    Carcinogenesis; 1997 May; 18(5):1075-83. PubMed ID: 9163699
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemopreventive effects of melatonin on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats.
    Rahman KM; Sugie S; Watanabe T; Tanaka T; Mori H
    Nutr Cancer; 2003; 47(2):148-55. PubMed ID: 15087267
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combined supplementation of vanadium and 1alpha,25-dihydroxyvitamin D3 inhibit placental glutathione S-transferase positive foci in rat liver carcinogenesis.
    Basak R; Chatterjee M
    Life Sci; 2000 Dec; 68(2):217-31. PubMed ID: 11191639
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppressive effect of enzymatically modified isoquercitrin on phenobarbital-induced liver tumor promotion in rats.
    Morita R; Shimamoto K; Ishii Y; Kuwata K; Ogawa B; Imaoka M; Hayashi SM; Suzuki K; Shibutani M; Mitsumori K
    Arch Toxicol; 2011 Nov; 85(11):1475-84. PubMed ID: 21445586
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlation of O4-ethyldeoxythymidine accumulation, hepatic initiation and hepatocellular carcinoma induction in rats continuously administered diethylnitrosamine.
    Dyroff MC; Richardson FC; Popp JA; Bedell MA; Swenberg JA
    Carcinogenesis; 1986 Feb; 7(2):241-6. PubMed ID: 2868805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suppressive effect of liver tumor-promoting activities in rats subjected to combined administration of phenobarbital and piperonyl butoxide.
    Morita R; Yafune A; Shiraki A; Itahashi M; Akane H; Nakane F; Suzuki K; Shibutani M; Mitsumori K
    J Toxicol Sci; 2013; 38(5):679-88. PubMed ID: 24025784
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of the age of B6C3F1 mice on phenobarbital promotion of diethylnitrosamine-initiated liver tumors.
    Klaunig JE; Weghorst CM; Pereira MA
    Toxicol Appl Pharmacol; 1987 Aug; 90(1):79-85. PubMed ID: 3629593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.